Book Review

The Biotech Investor’s Bible

By George Wolff

Biotechnology is complex, but the Biotech Investor’s Bible, published by John Wiley and Sons, cuts through all the high-tech jargon to give investors a clear picture of the exploding field.

You don’t have to be a rocket scientist to know that biotechnology presents remarkable investment opportunities in an industry on the threshold of incomparable growth. Biotechnology stands on the brink of curing many major diseases and reconfiguring critical industries, such as pharmaceuticals and forestry, petrochemicals and agriculture. The future for investors looms limitless.

However, as in every other field, investors need to know the skinny. The Biotech Investor’s Bible offers well-tested strategies and techniques to reduce risk and increase returns.

The book touches on several key themes:

• The steps you must know in order to assess the biotech market •
• A comprehensive look at 185 major biotech companies •
• Guidelines to follow when planning your biotech portfolio •
• An overview of the latest biotech therapies and breakthroughs •
• Tips on how to find sound and promising companies in the sector •
• An easy-to-understand introduction to the science and technology in the field •

Few analysts have the inside knowledge and the ability to convey as Wolff who is a journalist and consultant to firms in the investment industry. He has reported on more than 200 biotechnology companies.

Wolff’s book provides an overview of the industry that many analysts consider the most important business sector in the next century. He focuses on the financial forces that drive the complex biotech industry and presents many sensible investment criteria.

 To give readers a clear insight to the industry, he explains the following:

• Guidelines and commonsense methods for picking companies
• Details on new technologies and innovations
• Advice on how to pick lesser known companies with unrealized value
• Insights on how to structure a biotech portfolio
• A breakdown of 185 major biotech companies

Every investors, no matter the size of their portfolios, should have their eye on the biotechnology market. It will affect every sector of business from oil to insurance and mining to medicine.

Reading the Biotechnology Investor’s Bible can provide investors with a fundamental knowledge of the industry that will change the world in this century and cause strong ripplings through biotechnology market, creating limitless opportunities for investors.

By Frank Szivos, Editor Angel Investor News

back to: top  reviews  home

Buy this book from: